Resultats de la cerca - Eric M. Robinson
- Mostrar 1 - 2 resultats de 2
-
1
Sensitivity of plasma BRAF<sup>mutant</sup> and NRAS<sup>mutant</sup> cell‐free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non‐RECIST disease p... per Gregory Chang, Jyothirmayee S. Tadepalli, Yongzhao Shao, Yilong Zhang, Sarah A. Weiss, Eric M. Robinson, Cindy Spittle, Manohar R. Furtado, Dawne N. Shelton, George Karlin‐Neumann, Anna C. Pavlick, Iman Osman, David Polsky
Publicat 2015Artigo -
2
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies per Luping Lin, Amit J. Sabnis, Elton Chan, Victor Olivas, Lindsay Cade, Evangelos Pazarentzos, Saurabh Asthana, Dana S. Neel, Jenny Yan, Xinyuan Lu, Luu Pham, Mingxue M Wang, Niki Karachaliou, María González Cao, José Luís Manzano, José Luis Ramírez, J.M. Sanchez Torres, Fiamma Buttitta, Charles M. Rudin, Eric A. Collisson, Alain P. Algazi, Eric M. Robinson, Iman Osman, Eva Muñoz‐Couselo, Javier Cortés, Dennie T. Frederick, Zachary A. Cooper, Martin McMahon, Antonio Marchetti, Rafael Rosell, Keith T. Flaherty, Jennifer A. Wargo, Trever G. Bivona
Publicat 2015Artigo
Eines de cerca:
Matèries relacionades
Biology
Cancer
Cancer research
Biochemistry
Biomarker
Cell biology
Colorectal cancer
Confidence interval
Disease
Effector
Gastroenterology
Genetics
Hippo signaling pathway
Internal medicine
KRAS
MAPK/ERK pathway
MEK inhibitor
Medicine
Melanoma
Neuroblastoma RAS viral oncogene homolog
Oncology
Pathology
Progressive disease
Response Evaluation Criteria in Solid Tumors
Signal transduction